Industry reports
Editor highlights

Publication dates

data types

Melanoma Market and Forecasts, April 2014

You might be interested in: cancer, medicine, breast cancer, more »


 
1-10 of about 200 reports for Melanoma

Global Pharmaceutical Sector Brief Analysis

  • Industry report
  • February 2013
  • 55 pages

... Including global investigator-initiated trials (iits) in multiple indications: hcc, net, crc, melanoma establish chemosat as the standard of care (soc) for disease control in the liver 16 delcath systems ...

Pharmaceutical Sector Analysis in The United States

  • Industry report
  • January 2013
  • 54 pages

... By the fda, fda approval of the company's nda for the treatment of metastatic ocular melanoma to the liver, adoption, use and resulting sales, if any, for the chemosaturation system in the united states ...

Pharmaceutical Sector Analysis in The United States

  • Industry report
  • January 2013
  • 54 pages

... By the fda, fda approval of the company's nda for the treatment of metastatic ocular melanoma to the liver, adoption, use and resulting sales, if any, for the chemosaturation system in the united states ...

U.S. Pharmaceutical Business Brief Analysis

  • Industry report
  • December 2012
  • 52 pages

... By the fda, fda approval of the company's nda for the treatment of metastatic ocular melanoma to the liver, adoption, use and resulting sales, if any, for the chemosaturation system in the united states ...

The Chinese Pharmaceutical Industry Brief Analysis

  • Industry report
  • December 2012
  • 52 pages

... By the fda, fda approval of the company's nda for the treatment of metastatic ocular melanoma to the liver, adoption, use and resulting sales, if any, for the chemosaturation system in the united states ...

Pharmaceutical Sector Analysis in The United States and Germany

  • Industry report
  • March 2013
  • 56 pages

... S nda for the treatment of metastatic ocular melanoma to the liver, adoption, use and resulting sales, if any, for the delcath hepatic delivery system in the united states, adoption, use and resulting ...

U.S. Pharmaceutical Industry Brief

  • Industry report
  • September 2012
  • 50 pages

... Of metastatic melanoma to the liver, adoption, use and resulting sales, if any, in the united states, approval of the chemosat system in foreign markets, approval of the current or future chemosaturation system ...

U.S. Pharmaceutical Industry Brief

  • Industry report
  • May 2012
  • 49 pages

... Of metastatic melanoma to the liver, adoption, use and resulting sales, if any, in the united states, approval of the chemosat system in foreign markets, approval of the current or future chemosaturation system ...

Pharmaceutical Sector in The United States

  • Industry report
  • August 2012
  • 50 pages

... Of metastatic melanoma to the liver, adoption, use and resulting sales, if any, in the united states, approval of the chemosat system in foreign markets, approval of the current or future chemosaturation system ...

U.S. Pharmaceutical Industry Brief

  • Industry report
  • July 2012
  • 49 pages

... Of metastatic melanoma to the liver, adoption, use and resulting sales, if any, in the united states, approval of the chemosat system in foreign markets, approval of the current or future chemosaturation system ...


» Read our Company Profiles

1 Companies for Melanoma

Roche Holding AG

Switzerland

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.